Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse

Citations

WEB OF SCIENCE

0
제목
Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse
저자
Al-Shaibani, Eshrak; Cai, Yu; Song, Xianmin; Al Zahrani, Mohsen; Elemary, Mohamed; Alhumaid, Muhned; Alkhaldi, Hanan; Saad, Ayman; Bbiavasco, Francesc; Zeiser, Robert; Moon, Joon Ho; Sohn, Sang Kyun; Mattsson, Jonas; Kim, Dennis Dong Hwan
DOI
10.1182/blood-2024-211761
발행일
2024-11-05
유형
Meeting Abstract
저널명
Blood
권
144
페이지
4930 ~ 4931